Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CD-HLASENS

Financiado

Cerrado

Celiac Disease HLA typing using microfabricated genoSENSarray

Coeliac disease (CD) is a gluten-sensitive enteropathy that affects as much as 1% of the population. Patients with CD should maintain a lifelong gluten-free diet, in order to avoid serious complications. It is essential to diagnos... ver más

31/03/2013

URV

45K€

Presupuesto del proyecto: 45K€

Líder del proyecto

UNIVERSIDAD ROVIRA I VIRGILI No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 8

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-03-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

URV

0.00€ | Lider

Proyectos interesantes

CD-MB

Medical Technol...

Nanotechnology

30K€ Cerrado

ECLOBIOSENS

Medical Technol...

Data Science

162K€ Cerrado

GRANROSE

Medical Technol...

Data Science

130K€ Cerrado

BES-2015-073249

Medical Technol...

Nanotechnology

93K€ Cerrado

BES-2015-073255

Medical Technol...

Nanotechnology

93K€ Cerrado

PTQ2019-010354

Medical Technol...

Data Science

80K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSIDAD ROVIRA I VIRGILI No se ha especificado una descripción o un objeto social para esta compañía.

Total investigadores 8

Presupuesto del proyecto 45K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Coeliac disease (CD) is a gluten-sensitive enteropathy that affects as much as 1% of the population. Patients with CD should maintain a lifelong gluten-free diet, in order to avoid serious complications. It is essential to diagnose CD at the earliest possible conjecture. The Human Leukocyte Antigen system (HLA) is the human major histocompatibility complex. HLA typing is fundamental in hystocompatibility and previous to solid organ and bone marrow transplantation. In CD, HLA typing can find application in establishing the genetic risk and the association between certain HLA types. The overall objective of CD-HLAsens is therefore to develop a generic technological platform for CD point-of-care diagnostics capable of genomic detection with electrochemical transduction. Genosensors microarrays for the screening of CD disease will be developed based on the detection of nucleic acids associated with genetic predisposition, i.e. HLA typing. Such detection strategy could be used for general population screening but also for neonatal screening. Together with classical assay formats, novel biomolecule detection schemes based on supramolecular associations will be developed with the aim to fine tune the specificity and sensitivity of the sensors. The Researcher will design, new surface chemistry for the functionalisation and operation of the genosensors arrays based on the experiences gained during his previous MC fellowship and new research avenues he has identified (novel sensor surface patterning, electrochemical detection schemes for low resolution HLA typing). In addition, the researcher proposes to continue the successful development of a microfabricated genosensors array, focusing on sensor and microfluidics integration as well as connectivity issues (on chip integration and assay (HLA typing in <15 minutes)). Finally, more emphasise should be brought on the consideration of regulations and commercialisation considera

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores